The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Prof. Maria Generosa (Marisa) Crespo-Leiro, MD, PhD, FESC, FHFA, FHFSA
Head of the Heart Failure (HF) and Heart Transplantation (HT) Unit at the Hospital Universitario A Coruña, La Coruña (Spain). Professor of Medicine at the University of Coruña (UDC) in La Coruña (Spain). She obtained her MD at the University of Santiago de Compostela, Specialisation in Cardiology at Clinica Puerta de Hierro in Madrid and PhD from Universidad Autónoma de Madrid.
She served at several scientific societies: President of the Spanish Working Group on HF and HT (2003-2007). Member of the Board of Directors of the International Society for Heart and Lung Transplantation (ISHLT) (2010-1013). Member of the Board of the HF Association (HFA) of the European Society of Cardiology (ESC) (2012-2018). Secretary of the HFA Executive Committee (2016-2018). Chair of the HFA Advanced HF Committee (2017-2018). Member of ESC Education Committee (2018-2020). Member of HFA Advanced HF Committee (2022-2024). Since October 2023 she is “Vice-President elect” of the Spanish Society of Cardiology.
Her main fields of research and interest are HF and HT and she is author or co-author of more than 365 papers referenced in Pubmed (h-index 57). She chaired the Spanish Consensus Conference on Heart Transplantation (2007), the ESC HF Long Term Registry (2013-2016), and the Spanish Post-Heart Transplant Tumor Registry (ongoing). She chaired the ESC-HFA Position Statement on Advanced HF (2018) and participated in the “2021 ESC Heart Failure Guidelines Task Force (2021) and in the “2023 Update of 2021 ESC Heart Failure Guidelines Task Force (2023).
